Pfizer launches new website for migraine, respiratory offerings

Pfizer Inc (PFE.N) is launching a new website to promote and improve access to its health care offerings for migraine and respiratory illnesses.
The drugmaker said on Tuesday that it launched the site called PfizerForAll to help patients get access to treatments like its COVID-19 drug Paxlovid and its migraine pill Nurtec by offering services like telehealth appointments and diagnostic tests.